NeoRx adds to coffers with $19 million equity investment

By AuntMinnie.com staff writers

April 25, 2000 --

Radiotherapy firm NeoRx has raised more than $18 million from a private sale of 1.7 million shares of newly-issued common stock to a group of institutional investors. The Seattle-based firm plans to use the proceeds to advance its R&D programs, including its skeletal targeted radiotherapy (STR) and Pretarget works-in-progress technologies. NeoRx now has cash and cash equivalents of $36 million.

By AuntMinnie.com staff writers
April 25, 2000

Copyright © 2000 AuntMinnie.com
 

To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking
account: